David Reese in the Xchange: From a Molecule to a Medicine

David Reese is executive vice president of research and development for the Amgen Corporation. On this episode of The Xchange, David helps demystify the process of drug development, discusses the unique challenges that COVID-19 presents, and shares his thoughts on STEM career paths today. Join us for “From a Molecule to a Medicine” on the Xchange. A new virtual interview series from LabXchange at Harvard University, the Xchange showcases the diverse roles, projects, and initiatives that make up the intersecting fields of science, education, and health. Hosted by LabXchange Faculty Director Robert Lue, our first season features a range of perspectives on the impact of COVID-19.